Per Sigvald Bakke

Per Sigvald Bakke's AcademicInfluence.com Rankings

Per Sigvald Bakke

Philosophy

#8663

World Rank

#12081

Historical Rank

Logic

#5690

World Rank

#7108

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Per Sigvald Bakke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Per Sigvald Bakke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Changes in forced expiratory volume in 1 second over time in COPD. (2011) (890)
A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci (2009) (761)
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012) (723)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity (2010) (605)
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers (2002) (519)
Variants in FAM13A are associated with chronic obstructive pulmonary disease (2010) (387)
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. (2012) (366)
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes (2017) (353)
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression (2005) (346)
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. (2013) (339)
Gender differences in COPD: are women more susceptible to smoking effects than men? (2009) (287)
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. (2015) (282)
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. (2014) (280)
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis (2017) (275)
Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. (1991) (264)
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. (2018) (257)
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. (2013) (257)
Effect of reducing indoor air pollution on women's respiratory symptoms and lung function: the RESPIRE Randomized Trial, Guatemala. (2009) (253)
Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. (1999) (247)
Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. (2006) (239)
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. (2012) (227)
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. (2013) (224)
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets (2017) (217)
Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors (1994) (217)
U‐BIOPRED clinical adult asthma clusters linked to a subset of sputum omics (2017) (210)
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell type and phenotype associations (2019) (200)
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study (2009) (197)
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort (2013) (193)
Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. (2010) (192)
How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? (1999) (191)
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study (2005) (190)
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. (2012) (187)
Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study (2004) (184)
Post-bronchodilator spirometry reference values in adults and implications for disease management. (2006) (180)
Mortality by level of emphysema and airway wall thickness. (2013) (175)
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease (2012) (174)
Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking (2009) (172)
The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. (2006) (171)
Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D (2012) (155)
Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity (2006) (151)
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. (2015) (149)
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. (2014) (146)
Lessons from ECLIPSE: a review of COPD biomarkers (2013) (140)
Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. (2000) (138)
Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality (2014) (138)
A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry (2015) (132)
Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). (2007) (132)
A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. (2010) (129)
Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. (2011) (129)
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. (2015) (128)
Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response. (1990) (126)
Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study (2002) (121)
Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. (2002) (121)
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. (2012) (119)
A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. (2015) (118)
Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. (1991) (116)
Long-term changes in adult asthma prevalence (2003) (110)
Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. (2010) (108)
Genome-wide association study of smoking behaviours in patients with COPD (2011) (106)
Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. (1995) (104)
The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. (2005) (102)
The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. (2011) (102)
Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. (2009) (97)
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. (2001) (97)
Bronchial responsiveness in a Norwegian community. (1991) (97)
Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 (2006) (90)
Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. (2013) (89)
Occupational airborne exposure and the incidence of respiratory symptoms and asthma. (2002) (89)
Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. (2001) (87)
Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey (2010) (87)
Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. (2008) (83)
Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. (2005) (83)
α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. (2010) (83)
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease (2018) (82)
The incidence of adult asthma: a review. (2005) (81)
Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease (2011) (80)
The effect of educational level on the incidence of asthma and respiratory symptoms. (2004) (80)
Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. (2003) (79)
Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. (2015) (76)
Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study (2014) (75)
Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. (2011) (75)
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. (2002) (75)
Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility (2013) (72)
Atopic and non-atopic asthma in a farming and a general population. (2004) (72)
Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. (2011) (71)
Hay fever, eczema and urticaria in southwest Norway (1990) (69)
Increased prevalence of chronic obstructive pulmonary disease in a general population. (2013) (69)
Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. (2002) (68)
Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial (2011) (67)
Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exposure matrices (ECOJEM) (2000) (67)
Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma (2019) (64)
Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries (2012) (64)
Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. (2005) (63)
IL-17-high asthma with features of a psoriasis immunophenotype. (2019) (62)
Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs (2010) (62)
Complications and discomfort of bronchoscopy: a systematic review (2016) (62)
Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population (2016) (62)
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly (2003) (61)
Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. (2011) (59)
Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease: Do They Influence Patient-Related Outcomes? (2013) (55)
Remission of respiratory symptoms by smoking and occupational exposure in a cohort study (2004) (54)
High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. (1994) (54)
Function with Measured Carbon Monoxide Concentrations among Nonsmoking Women Exposed to Household Air Pollution: The RESPIRE Trial, Guatemala (2014) (54)
Indoor exposures and respiratory symptoms in a Norwegian community sample (2005) (53)
A simple algorithm for the identification of clinical COPD phenotypes (2017) (53)
Recommendations for epidemiological studies on COPD (2011) (52)
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease (2017) (52)
Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease (2006) (52)
Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults (2012) (52)
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis (2018) (52)
Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta‐analysis of 16,707 Subjects (2017) (52)
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk (2018) (51)
One-year change in health status and subsequent outcomes in COPD (2015) (51)
Opportunities and Challenges in the Genetics of COPD 2010: An International COPD Genetics Conference Report (2011) (50)
Does smoking affect the outcome of patient education and self-management in asthmatics? (2003) (50)
Predictors of smoking cessation in patients admitted for acute coronary heart disease (2005) (50)
Changes in respiratory symptoms and health-related quality of life. (2007) (49)
Candidate genes for COPD in two large data sets (2010) (49)
Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD (2010) (49)
Non-response bias in a postal questionnaire survey on respiratory health in the old and very old (2003) (49)
Relation of occupational exposure to respiratory symptoms and asthma in a general population sample: self-reported versus interview-based exposure data. (2001) (48)
Exposure to Household Air Pollution from Wood Combustion and Association with Respiratory Symptoms and Lung Function in Nonsmoking Women: Results from the RESPIRE Trial, Guatemala (2014) (48)
Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD (2016) (48)
Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. (2015) (46)
Randomised comparison of needle aspiration and chest tube drainage in spontaneous pneumothorax (2016) (46)
Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. (2013) (45)
Comparison of respiratory symptoms questionnaires. (2000) (45)
Stratification of asthma phenotypes by airway proteomic signatures. (2019) (44)
Body composition and plasma levels of inflammatory biomarkers in COPD (2010) (43)
TNF-α is associated with loss of lean body mass only in already cachectic COPD patients (2012) (43)
Feasible and simple exclusion criteria for pulmonary reference populations (2007) (41)
COPD and co-morbidities: Mortality in COPD patients discharged from hospital: The role of treatment and co-morbidity Respir Res 2006;7:109 (2006) (41)
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial (2012) (40)
Socioeconomic risk factors for lung function decline in a general population (2010) (40)
Genome‐Wide Association Study of the Genetic Determinants of Emphysema Distribution (2016) (40)
Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. (1992) (40)
Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. (2008) (40)
Bias in retrospective studies of trends in asthma incidence (2004) (39)
Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD (2011) (38)
Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation (2010) (38)
Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. (2000) (38)
The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease (2019) (37)
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19 q 13 (2012) (37)
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study (2020) (36)
Sex differences between women and men with COPD: A new analysis of the 3CIA study. (2020) (36)
The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. (2012) (36)
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts (2020) (35)
Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community. (1996) (34)
Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease (2011) (34)
Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma (2017) (33)
Exposure to environmental tobacco smoke in a general population. (2007) (33)
Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. (2010) (33)
Erratum: “Exposure to Household Air Pollution from Wood Combustion and Association with Respiratory Symptoms and Lung Function in Nonsmoking Women: Results from the RESPIRE Trial, Guatemala” (2016) (32)
Integration of Molecular Interactome and Targeted Interaction Analysis to Identify a COPD Disease Network Module (2018) (32)
Healthy hire effect, job selection and inhalation exposure among young adults with asthma (2010) (32)
Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease (2014) (31)
Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. (2013) (31)
Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. (1990) (30)
Sex‐Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women (2017) (30)
Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD (2015) (30)
Treatable traits in the European U‐BIOPRED adult asthma cohorts (2018) (30)
Does smoking cessation improve Quality of Life in patients with coronary heart disease? (2006) (30)
Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. (2006) (30)
Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD (2017) (30)
Excessive costs of COPD in ever-smokers. A longitudinal community study. (2011) (30)
Variability of within-breath reactance in COPD patients and its association with dyspnoea (2014) (29)
CTLA4 gene polymorphisms are associated with chronic bronchitis (2009) (29)
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies (2010) (29)
Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. (2016) (29)
Different COPD Disease Characteristics are Related to Different Outcomes in the 6-minute Walk Test (2012) (29)
Protected sampling is preferable in bronchoscopic studies of the airway microbiome (2017) (29)
Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. (2013) (29)
High prevalence of respiratory symptoms during air travel in patients with COPD. (2011) (29)
Serum house-dust-mite antibodies and reduced FEV1 in adults of a Norwegian community. (1995) (29)
Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study (2011) (28)
Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients (2014) (27)
Association of the FAM46A Gene VNTRs and BAG6 rs3117582 SNP with Non Small Cell Lung Cancer (NSCLC) in Croatian and Norwegian Populations (2015) (26)
Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? (2010) (26)
DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease (2014) (25)
Applicability of the single-breath carbon monoxide diffusing capacity in a Norwegian Community Study. (1998) (25)
Increased circulating levels of alpha1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. (2001) (25)
No impact of early real-time PCR screening for respiratory viruses on length of stay and use of antibiotics in elderly patients hospitalized with symptoms of a respiratory tract infection in a single center in Norway (2013) (25)
Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway. (2007) (25)
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population (2018) (25)
Is sense of coherence a predictor of lifestyle changes in subjects at risk for type 2 diabetes? (2015) (24)
Occupational exposure and incidence of respiratory disorders in a general population. (2009) (24)
Hospital doctors' attitudes toward giving their patients smoking cessation help (2007) (24)
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients (2019) (23)
A Genome-wide analysis of the response to inhaled beta2-agonists in Chronic Obstructive Pulmonary Disease (2015) (23)
Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. (2014) (22)
Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients (2017) (22)
Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease (2018) (22)
Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease. (2010) (21)
Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. (2019) (21)
Physical activity and longitudinal change in 6-min walk distance in COPD patients. (2014) (21)
Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD (2014) (21)
Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development (2019) (21)
[Prevalence of home ventilation therapy in Norway]. (2009) (20)
HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer (2009) (20)
Explained variance for blood gases in a population with COPD (2012) (20)
Variable Susceptibility to Cigarette Smoke‐Induced Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility (2017) (20)
Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin. (1989) (19)
The Association Of Genome-Wide Significant Spirometric Loci With COPD Susceptibility (2011) (19)
The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences (2014) (19)
Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease (2013) (19)
Genetic association between human chitinases and lung function in COPD (2012) (19)
Pulmonary gas exchange and educational level: a community study (2004) (19)
Reference values for within‐breath pulmonary impedance parameters in asymptomatic elderly (2013) (18)
The association of tidal EFL with exercise performance, exacerbations, and death in COPD (2017) (18)
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort (2017) (18)
Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. (2019) (18)
CHARACTERISTICS, STABILITY AND OUTCOMES OF THE GOLD 2011 COPD GROUPS IN THE ECLIPSE COHORT (2013) (18)
Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort (2019) (17)
Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study (2017) (17)
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort (2020) (17)
Protein-altering germline mutations implicate novel genes related to lung cancer development (2020) (17)
Coagulation markers as predictors for clinical events in COPD (2020) (16)
The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood (2006) (16)
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort (2018) (16)
Occupational airborne exposure of the general population of a Norwegian county. (1992) (16)
Macrophage migration inhibitory factor, a role in COPD. (2016) (16)
Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates (2008) (16)
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization (2013) (15)
Beyond GWAS in COPD: Probing the Landscape between Gene-Set Associations, Genome-Wide Associations and Protein-Protein Interaction Networks (2014) (15)
Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort. (2018) (15)
Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer (2016) (14)
Predictors of health-related quality of life changes after lifestyle intervention in persons at risk of type 2 diabetes mellitus (2014) (14)
A comparison of nasopharyngeal and oropharyngeal swabbing for the detection of influenza virus by real-time PCR (2013) (14)
The GOLD Classification Has Not Advanced Understanding of COPD (2004) (14)
The airway microbiota and exacerbations of COPD (2020) (13)
Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients (2016) (13)
Relationships between hand‐rolled cigarettes and primary lung cancer: A Norwegian experience (2009) (13)
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome. (2018) (13)
Factors affecting growth of FEV1. (2003) (13)
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. (2007) (13)
Serum respiratory virus antibodies: predictor of reduced one-second forced expiratory volume (FEV1) in Norwegian adults. (1996) (12)
New genetic signals for lung function highlight pathways and pleiotropy, and chronic obstructive pulmonary disease associations across multiple ancestries (2018) (12)
Factors affecting growth of FEV 1 (2003) (12)
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations (2021) (12)
Work-related asthma: prevalence estimates by sex, age and smoking habits in a community sample. (2000) (12)
Total serum IgE and FEV1 by respiratory symptoms and obstructive lung disease in adults of a Norwegian community (1995) (12)
Coronary artery calci fi cation is increased in patients with COPD and associated with increased morbidity and mortality (2014) (12)
Mapping atopic dermatitis and anti-IL-22 response signatures to Type 2-low severe neutrophilic asthma. (2021) (11)
Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients (2017) (11)
Non-response in epidemiological studies - How to cope with it? (2010) (11)
Aspects of healthcare utilisation in self‐reported obstructive lung disease (2009) (11)
Guideline adherence in hospital recruited and population based COPD patients (2018) (11)
Reproducibility of indoor environment characteristics obtained in a walk through questionnaire. A pilot study. (1999) (11)
The single-breath transfer factor for carbon monoxide and respiratory symptoms in a Norwegian community sample. (1999) (11)
Peak oxygen uptake and breathing pattern in COPD patients – a four-year longitudinal study (2015) (10)
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol (2020) (10)
Smoking status, disease duration, and educational level in females, are related to asthma school participation. (2000) (10)
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers (2018) (10)
Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease Minimal Clinically Important Difference for Death or Hospitalization on behalf of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators (2013) (10)
Predictors for PaO2 and Hypoxemic Respiratory Failure in COPD–A Three-Year Follow-up (2014) (10)
Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores (2017) (9)
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux (2019) (9)
External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study (2019) (9)
Lung hyperinflation and functional exercise capacity in patients with COPD – a three-year longitudinal study (2018) (9)
Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients (2014) (9)
Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. (2016) (8)
The Relationship of Educational Attainment with Pulmonary Emphysema and Airway Wall Thickness. (2015) (8)
[Treatment of obstructive sleep apnea]. (2005) (8)
Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. (1995) (8)
Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD. (2015) (8)
Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients (2015) (8)
Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status. (2019) (8)
Genome-Wide Association Study Of Smoking Behaviors In COPD Patients (2011) (8)
Standardized submaximal exercise testing in never smokers: a normative study. (2001) (8)
Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. (2019) (8)
Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques (2005) (8)
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data (2020) (7)
Participation in research bronchoscopy: a literature review (2016) (7)
Genetic Associations and Architecture of Asthma-COPD Overlap (2022) (7)
Pneumothorax size measurements on digital chest radiographs: Intra- and inter- rater reliability. (2015) (7)
Complications and discomfort after research bronchoscopy in the MicroCOPD study (2020) (7)
Expanded genetic landscape of chronic obstructive pulmonary disease reveals heterogeneous cell type and phenotype associations (2018) (6)
Non-Response in Telephone Surveys of Copd Patients Does Not Introduce Bias (2013) (6)
Multi-ancestry genome-wide association study improves resolution of genes, pathways and pleiotropy for lung function and chronic obstructive pulmonary disease (2022) (6)
Transthoracic fine‐needle aspiration in the aetiological diagnosis of community‐acquired pneumonia (2009) (6)
On the simultaneous association analysis of large genomic regions: a massive multi-locus association test (2014) (6)
Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD (2015) (6)
Longterm mechanical ventilation in ALS – Outcome and perspective. A 12 year national register study of non-invasive and invasive ventilation in Norway (2015) (6)
Repeatability of health economic data in COPD. (2008) (6)
Genome‐Wide Association Analysis of Single‐Breath DlCO (2019) (5)
Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease (2014) (5)
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study (2021) (5)
One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis (2020) (5)
Trends in symptoms of obstructive lung disease in Norway. (2004) (5)
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation (2021) (5)
Abstracts and proceedings from II Scandinavian COPD research symposium (2007) (5)
Respiratory symptoms and mortality in four general population cohorts over 45 years. (2020) (5)
The association between body composition and self-reported co-morbidity in subjects with chronic obstructive pulmonary disease (2012) (5)
[The effect of patient education in asthma, a randomized controlled trial]. (2002) (5)
Nordic physicians’ management of asthma and chronic obstructive pulmonary disease (2006) (5)
Common and rare variants genetic association analysis of cigarettes per day among ever smokers in COPD cases and controls. (2018) (5)
Coagulation markers in COPD (2018) (5)
The first U-BIOPRED blood handprint of severe asthma (2015) (4)
Risk factors for rehospitalization in COPD : Health status, anxiety and depression (2005) (4)
[Smoking cessation practice among Norwegian hospital physicians]. (2000) (4)
On the follow‐up of genome‐wide association studies: an overall test for the most promising SNPs (2011) (4)
Characteristics of hospitalised patients with COPD in the Nordic countries (2006) (4)
[Changes in smoking habits among medical students in Bergen 2004-2006]. (2008) (4)
Comorbidities in current COPD guidelines (2013) (4)
Medication adherence in patients with severe asthma prescribed oral corticosteroids in the U-BIOPRED cohort. (2021) (4)
CT-defined emphysema in COPD patients and risk for change in desaturation status in 6-min walk test. (2021) (4)
Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility (2013) (3)
Neutrophil Gelatinase Associated Lipocalin - a biomarker in Chronic Obstructive Pulmonary Disease (2010) (3)
Clustering analysis of clinical variables in U-BIOPRED adult asthma cohort (2014) (3)
Bronchitic symptoms and their reltion to FEV1 in Italy, Sweden and Norway (2001) (3)
Motivation and response rates in bronchoscopy studies (2019) (3)
Designing studies for diagnostic tests (2008) (3)
Costs of COPD exacerbations in a general population. (2018) (3)
Clinical data discriminating between adults with positive and negative results on bronchodilator testing. (2008) (3)
[Do health personnel talk about passive smoking with parents of small children?]. (2000) (3)
Characteristics of hospitalized patients with obstructive lung disease (2002) (3)
Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort (2018) (3)
Change in pulmonary diffusion capacity in a general population sample over 9 years (2016) (3)
CHRONIC AIRWAY SYMPTOMS AND LUNG FUNCTION AMONG WOMEN IN A RURAL COMMUNITY IN GUATEMALA WITH HIGH INDOOR AIR POLLUTION LEVELS (2004) (3)
Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort (2015) (3)
New syringes for arterial blood sampling (1986) (3)
Asthma and health‐related quality of life – effect of adjusting for potential confounders (2008) (3)
A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry (2015) (3)
[Smoking habits among medical students in Bergen]. (2005) (3)
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease. (2016) (3)
Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (2019) (3)
Repeated bronchoscopy in health and obstructive lung disease: is the airway microbiome stable? (2021) (3)
Occupational Dust Exposure And Airway Wall Thickening And Emphysema By Computed Tomography (CT) (2010) (2)
Nonspecific challenge test for the diagnosis of asthma in a general population sample. (1992) (2)
Genome-Wide Association Study In Two Independent COPD Populations Identifies Variants In The BICD1 Gene Associated With Emphysema (2010) (2)
Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease (2017) (2)
Reference values for FEV1, FVC and FEV1/FVC in Norway (2015) (2)
[Medication practice and personal knowledge of the disease among patients with obstructive lung disease]. (1998) (2)
Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort (2017) (2)
Genome-Wide Association Studies Identify CHRNA5/3 and HTR4 in the Development of Airﬂow Obstruction (2012) (2)
Risk factors for lung cancer in COPD (2017) (2)
U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes (2018) (2)
Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma (2020) (2)
[Allergic diseases in Norway. Operative definition, occurrence and risk factors]. (1992) (2)
Which Disease Characteristics in COPD Are Related to Comorbidities (2009) (2)
Obstructive lung disease in patients within the the hospital in the Nordic countries (2000) (1)
The Excess Treatment-related Costs Of COPD By Severity. A Twelve-month Follow-up Study (2010) (1)
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients (2014) (1)
The microbiome of COPD in protected, bronchoscopic airway samples (2017) (1)
A Genome-wide Association Study Identifies FAM13A As A COPD Susceptibility Locus (2010) (1)
Oxygen desaturation in the six minute walk test is a predictor of decline in muscle mass in COPD patients (2015) (1)
Comparison of drainage and aspiration in patients with spontaneous pneumothorax (2014) (1)
Soluble Receptor For Advanced Glycation Endproducts (sRAGE) Is A Biomarker Of Emphysema In The ECLIPSE Cohort (2012) (1)
Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort (2017) (1)
The Impact Of Nonlinear Smoking Effects In The Identification Of Gene-by-Smoking Interactions In COPD Genetics Studies (2010) (1)
X Chromosome Genetic Associations in COPD (2019) (1)
Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study (2023) (1)
Genome-Wide Association Study Of Quantitative CT-Defined Emphysema Distribution In COPD (2010) (1)
Low CT bone radio density is associated with adverse clinical features and increased coronary artery calcification in COPD (2012) (1)
Needle aspiration should be considered as primary intervention option for stable patients with spontaneous pneumothorax. (2017) (1)
Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD (2016) (1)
Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort (2018) (1)
Associated factors with persistent airflow limitation in asthma in U-BIOPRED (2013) (1)
Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study (2019) (1)
Associations between quantitative computed tomography (qCT) measures of emphysema and mortality (2011) (1)
The minimal clinically important difference (MCID) for the six minute walk (6MW) test in COPD in relation to death (2012) (1)
[Genetics in chronic obstructive pulmonary disease]. (2009) (1)
Contributions of Airway Wall Thickening and Emphysema to Airflow Limitation: ”Evaluation of COPD Longitudinally To Identify Predictive Surrogate Endpoints” (ECLIPSE) Study. (2009) (1)
[An interdisciplinary educational program about pulmonary obstructive disease in family practice]. (2005) (1)
Clinical and histological comparison of smoking and non-smoking patients with severe asthma in the U-BIOPRED cohort (2014) (1)
A Genome-wide analysis of the response to inhaled beta 2-agonists in Chronic Obstructive Pulmonary Disease (2016) (1)
The association between body composition and self-reported comorbidity in subjects with chronic obstructive pulmonary disease (2013) (1)
Quantitative Assessment of Emphysema Is Associated with Body Composition. (2009) (1)
[Obstructive lung disease in a Norwegian population group--risk factors and occurrence]. (1992) (1)
University of Groningen Genome-wide association studies identify CHRNA 5 / 3 and HTR 4 in the development of airflow obstruction (2017) (1)
Macrophage migration inhibitory factor (MIF), a biomarker in COPD? (2014) (1)
Fever, hospitalization and healthcare utilization after research bronchoscopy (2014) (1)
Variants Tagging Serpina1 And Il27 Show Significant Association With COPD In A Meta-Analysis With Over 16,700 Subjects (2016) (1)
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations (2013) (1)
Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD (2020) (0)
The Relationship between Respiratory Symptoms, Obstructive Lung Disease, and Health Related Quality of Life in the ECRHS. (2009) (0)
Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts (2014) (0)
[Documentary soap at the Haukeland hospital--an ethical dilemma?]. (2000) (0)
A Genome-Wide Association Study of > 250,000 Subjects Identifies Novel Risk Loci for COPD (2018) (0)
Integration Of Gwas, eQTL, And Encode Data Identify Regulatory Variants And Cell Types Contributing To Patterns Of Radiographic Emphysema (2014) (0)
[Middle-aged man with fever, hypoxia and bilateral alveolar infiltrates]. (2007) (0)
Chronic cough and phlegm in relation to occupational exposures in a prospective cohort study (ECRHS III) (2015) (0)
The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts (2023) (0)
Slope and curvature of the relationship between ventilation and tidal volume in COPD patients (2013) (0)
Hospitalizations for chronic obstructive pulmonary disease: risk factors and possible interventiobs. (2003) (0)
Our results provide a quantitative approach for measuring smoke-related changes in the lung. ASSOCIATION OF SERPINE2 AND OTHER COPD CANDIDATE GENES TO DIFFERENT EMPHYSEMA SUBTYPES AND LUNG FUNCTION (0)
Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population (2020) (0)
MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients (2015) (0)
Characteristics of hospitalised patients with COPD in the Nordic countries: Respir Med 2006; published online ahead of print on 23 August 2006 as doi:10.1016/j.rmed.2006.03.022 (2006) (0)
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium (2014) (0)
Genetics Of Sputum Gene Expression Supports Two Distinct COPD Susceptibility Genes On Chromosome 15q25 (2011) (0)
Is vitamin D deficiency a risk factor for COPD exacerbations (2013) (0)
Subtypes of eosinophilic asthma with discrete gene pathway phenotypes (2019) (0)
Genetic association between human chitinases and lung function in COPD (2011) (0)
Running head : MIF , a role in COPD 16 Corresponding author : 17 (2016) (0)
Socioeconomic Status And Quantitatively Derived HRCT Measurements Of Emphysema And Airway Wall Thickness In COPD And Non-COPD Subjects (2010) (0)
The first U-BIOPRED sputum handprint of severe asthma (2015) (0)
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD (2023) (0)
Norwegian population-based studies: Risk factors for decrease in lung function; morbidity and mortality from obstructive lung disease (2000) (0)
What is the optimal sampling technique for assessing the microbiota with bronchoscopy (2016) (0)
Associations Between Clinical Factors And Indices Of Systemic Inflammation To The Presence Of Renal Failure In COPD Patients (2010) (0)
Changes in FEV1 over 8 years in COPD (2016) (0)
Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease of the Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate End-Points (ECLIPSE), Norway-Bergen cohort, National Emphysema Treatment Trial, and COPD Gene investigator (2011) (0)
Recommendations for epidemiological studies on COPD (2012) (0)
Indoor air pollutions and respiratory symptoms in a Norwegian community sample (2005) (0)
CRP, TNF-R1, OPG and Body Composition in COPD. (2009) (0)
Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-Invasively By Impuls Oscillometry (2012) (0)
Jarle Tor Rørvik (2018) (0)
Longitudinal Replication Of Severe Asthma Exhaled Breath Phenotypes By The U-Biopred Electronic Nose Platform (2016) (0)
Exacerbation History In COPD Patients With And Without Expiratory Flow Limitation (EFL) (2012) (0)
The impact on future risk of one moderate COPD exacerbation in GOLD A patients – a cohort study (2022) (0)
Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients (2011) (0)
How expensive is comorbidity in COPD (2009) (0)
Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients (2011) (0)
Polygenic Risk Scores in Chronic Obstructive Pulmonary Disease and Related Phenotypes (2020) (0)
Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study (2017) (0)
Relationship Between Lung Volumes And The Extent Of Emphysema As Assessed By Computed Tomography In The "Evaluation Of COPD Longitudinally To Identify Predictive Surrogate Endpoints" (ECLIPSE) Study (2011) (0)
Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer.: PD6-3-1 (2007) (0)
A genome-wide association study of COPD identiﬁes a susceptibility locus on chromosome 19q13 behalf ICGN, ECLIPSE, COPDGene (2012) (0)
The impact of exacerbations among subjects with COPD, what can we learn from 'big data'? (2018) (0)
[Immunoglobulin E, viral antibodies and obstructive lung disease in adults. The relation between antibody level in serum, lung function and non-specific bronchial reactivity]. (1998) (0)
[Pulmonary health among farmers]. (1995) (0)
The 2006 and 2011 GOLD classifications and five-years mortality in COPD (2013) (0)
LSC 2013 abstract - Simulated bronchoalveolar lavage: Oral bacterial contamination of the bronchoscope affects lavage results (2013) (0)
Mitochondrial DNA Polymorphisms Are Associated With COPD (2010) (0)
Validation of the COPD lung cancer screening score in a community based cohort of COPD patients (2015) (0)
Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients (2013) (0)
Predictors for longitudinal change in DLCO in a community based sample (2012) (0)
A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts (2022) (0)
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers (2018) (0)
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (2019) (0)
Predictors of Hypoxia and Hypercapnia in COPD Patients. (2009) (0)
Complications of research bronchoscopy in subjects with and without COPD (2017) (0)
Single breath transfer factor for carbon monoxide in patients with bronchial asthma and cold of a Norwegian community sample (1996) (0)
Predictors for longitudinal change in 6-minute walk distance in COPD patients (2012) (0)
Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study (2020) (0)
Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (2019) (0)
Can intra-breath variations of reactance predict dyspnea (2013) (0)
Genome Wide Association Study Of Exacerbation Phenotypes In COPD (2011) (0)
Health related quality of life and its effect on lung function (2011) (0)
Vitamin D Deficiency And Decline In Lung Function In COPD Patients (2012) (0)
Common Genetic Risk Variants Correlate With Hypoxemia Within COPD Cases In A Genome-Wide Association Study (2012) (0)
Static hyperinflation and decline in functional capacity in COPD patients (2017) (0)
non-response . Norway : causes and consequences of exposure and respiratory disorders in Postal survey on airborne occupational (0)
Predictors Of Severe Vitamin D Deficiency In A Cohort Of COPD Patients (2011) (0)
Changes in the induced sputum proteome during COPD exacerbations (2020) (0)
Predictors for developing hypoxic respiratory failure in COPD – A 3-year follow-up (2011) (0)
[Pneumothorax in severe asthma attacks]. (1987) (0)
Exercise-induced oxygen desaturation determinants including pulmonary emphysema in COPD: ECLIPSE data (2016) (0)
Body Compositional Shift in COPD Patients Stratified for BMI. (2009) (0)
Pulmonary cancer by level of emphysema and airway wall thickness in subjects with and without COPD (2014) (0)
Abstract 1214: TP53 affects SOX2 copy number alterations and expression in non-small cell lung cancer (2015) (0)
Oxygen Desaturation In The Six Minute Walk Test Predicts Mortality In COPD Patients (2012) (0)
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels (2019) (0)
High-dose iinhaled s steroids iin a asthmatics: m moderate e efficacy g gain and s suppression o of tthe h hypothalamic-pituitary-adrenal ((HPA) a axis (1994) (0)
[Indoor air pollution and pulmonary and respiratory tract diseases]. (1995) (0)
Productivity loss in ever-smoking COPD subjects from a general population (2011) (0)
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma (2019) (0)
Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients (2017) (0)
Who participates in a bronchoscopy study, and why? (2017) (0)
Common and rare variants analysis of smoking related traits among current and former smokers of European and African ancestry (2018) (0)
[Course of obstructive lung diseases]. (1993) (0)
O40-4 Lung function decline and copd prevalence in relation to occupational exposures in a prospective cohort study: the ecrhs III (2016) (0)
Testing Reported Genetic Determinants Of Lung Function From Large Population-Based Studies: Association With COPD And EQTL Analysis (2012) (0)
Growth differentiation factor-15 is a predictor for COPD exacerbations and survival (2015) (0)
One-year change in health status and outcomes in chronic obstructive pulmonary disease (2014) (0)
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) (2015) (0)
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use (2013) (0)
Risk charts of five-year mortality in COPD patients (2019) (0)
Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD (2016) (0)
Effect of Intermittent Oxygen Therapy Among COPD Patients without Severe Hypoxemia (2008) (0)
Author's response (2010) (0)
Title : Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD : results from the ECLIPSE study Running title : Oxygen desaturation and emphysema in COPD (2016) (0)
COPD exacerbations and predictors in a general population (2016) (0)
Contents Vol. 78, 2014 (2015) (0)
Exacerbation history in COPD patients with and without Expiratory Flow Limitation (EFL) measured by forced oscillometry technique (FOT) (2013) (0)
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study (2023) (0)
Genetic Risk for Body Mass and Mortality in COPD (2023) (0)
Correction: Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study (2015) (0)
MBL Deficiency and COPD. (2009) (0)
Follow-up desaturation in 6 minute walk tests and lung function decline in COPD patients (2018) (0)
Five Years Mortality And Arterial Blood Gases In COPD (2012) (0)
Genome-Wide Association Study Of Lung Function In COPD (2010) (0)
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations (2019) (0)
[Use of occupational anamnesis at a lung department]. (1988) (0)
European collaborative analyses on occupational risk factors for COPD using job exposure matrices (ECOJEM): performance of population-based job exposure-matrices. (1996) (0)
Clinical Consequences Of Observer Reliability In Estimation Of Pneumothorax Size Based On Digital Chest X-Rays (2012) (0)
Can the influenza vaccine response be predicted in COPD patients by clinical parameters (2015) (0)
Guilty pleasures and the healthy lung microbiota (2020) (0)
Emphysema is associated with increased risk of desaturation in 6 min walk test in COPD patients (2020) (0)
COPD phenotypes not linked to increased risk of coronary heart disease (2019) (0)
Polymorphisms in the SOD3 Gene Are Associated with Emphysema in COPD. (2009) (0)
Factors associated with coronary heart disease in COPD patients and controls (2022) (0)
COPD_A_194019 1639..1655 (2019) (0)
Genome Wide Association Study Of Body Mass Index And Fat Free Mass Index In COPD (2010) (0)
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway (2012) (0)
Peak oxygen uptake and breathing pattern in COPD patients – A four year longitudinal study (2015) (0)
end-expiratory pressure in obesity Expiratory flow limitation and intrinsic positive (2015) (0)
A Genome-Wide Association Study In COPD Identifies A Susceptibility Locus On Chromosome 19q13 (2011) (0)
Repeated bronchoscopy examination of the airway microbiome (2019) (0)
Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort (2017) (0)
Reference Values For Resistance And Reactance Measures From Impuls Oscillometry In Healthy Elderly (2010) (0)
A Genome-Wide Association Study Of Bronchodilator Responsiveness In Four Cohorts With COPD (2012) (0)
Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD (2011) (0)
Longitudinal change in peak oxygen uptake in COPD patients (2014) (0)
Explorer Genetics of sputum gene expression in chronic obstructive pulmonary disease (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Per Sigvald Bakke?

Per Sigvald Bakke is affiliated with the following schools:

University of Bergen

Per Sigvald Bakke's Academic­Influence.com Rankings

Why Is Per Sigvald Bakke Influential?

Per Sigvald Bakke's Published Works

Published Works

What Schools Are Affiliated With Per Sigvald Bakke?

Per Sigvald Bakke's AcademicInfluence.com Rankings